American Journal of Cardiology
Volume 104, Issue 12 , Pages 1624-1630 , 15 December 2009

Usefulness of the Duke Sudden Cardiac Death Risk Score for Predicting Sudden Cardiac Death in Patients With Angiographic (>75% Narrowing) Coronary Artery Disease

  • Brett D. Atwater, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: (919) 684-8111; fax: (919) 681-9260
    • ,
  • Vivian P. Thompson, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Richard N. Vest III, MD

      Affiliations

    • Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Linda K. Shaw, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Walter R. Mazzei Jr., MD

      Affiliations

    • Texas Heart Institute, Houston, Texas
    • ,
  • Sana M. Al-Khatib, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina
    • ,
  • Patrick M. Hranitzky, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina
    • ,
  • Tristram D. Bahnson, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina
    • ,
  • Eric J. Velazquez, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina
    • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina
    • Duke Translational Medicine Institute, Durham, North Carolina
    • ,
  • Kerry L. Lee, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina

Received 12 June 2009 ,Revised 21 July 2009 ,Accepted 21 July 2009.

References 

  1. Hlatky MA, Califf RM, Harrell FE, Lee KL, Mark DB, Pryor DB. Comparison of predictions based on observational data with the results of randomized controlled trials of coronary artery bypass surgery. J Am Coll Cardiol. 1988;11:237–245
  2. Mark DB, Nelson CL, Califf RM, Harrell FE, Lee KL, Jones RH, et al. Continuing evolution of therapy for coronary artery disease (Initial results from the era of coronary angioplasty). Circulation. 1994;89:2015–2025
  3. Newby LK, Lapointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203–212
  4. Heymans MW, Buuren SV, Knol DL, van Mechelen W, de Vet HCW. Variable selection under multiple imputation using bootstrap in a prognostic study. BMC Med Res Methodol. 2007;7:33
  5. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
  6. Ohman EM, Granger CB, Harrington RA, Lee KL. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA. 2000;284:876–878
  7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  8. Packer DL, Bernstein R, Wood F, Boehmer J, Carlson M, Frantz RP, et al. Impact of amiodarone versus implantable cardioverter defibrillator therapy on the mode of death in congestive heart failure patients in the SCDHeFT trial. Heart Rhythm. 2005;2(S38):AB20–AB22
  9. Owens DK, Sanders GD, Heidrenreich PA, McDonald KM, Hlatky MA. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J. 2002;144:440–448

 This study was independently funded through internal sources without influence or financial support from industry or the Centers for Medicaid and Medicare Services, Baltimore, Maryland.

PII: S0002-9149(09)01467-2

doi: 10.1016/j.amjcard.2009.07.042

American Journal of Cardiology
Volume 104, Issue 12 , Pages 1624-1630 , 15 December 2009

Article Tools

* Image Usage & Resolution